The University has been successful in obtaining grants totalling £1 million from the Medical Research Council (MRC) to support research into new medicines.
Professor Andrew Tobin, Director of the Leicester Drug Discovery and Diagnostics Centre, said: ‘This money will go directly into our front line projects aimed at developing drugs that protect the heart during a heart attack and developing novel treatments for cancer.”
The Leicester Drug Discovery and Diagnostics Centre at the University of Leicester is a specialised centre dedicated to the development of new medicines. The Centre has links with many of the world’s largest pharmaceutical companies including GlaxoSmithKline and Astra Zeneca. With highly training staff and state-of-the-art research infrastructure the Centre is designed to progress the basic research projects conducted at the University into new medicines and treatments for patients.
The MRC is making a total of £23.3m awards of which Leicester has been successful in securing £1m in Confidence in Concept and Proximity to Discovery awards. The MRC is accelerating innovative medical research with funding to take ground-breaking ideas from UK universities into industry and out to patients.
The announcement was made by Universities and Science Minister Jo Johnson. He said: “Our global scientific impact far exceeds our size as a nation, and our world class researchers help drive the engines of innovation keeping the UK at the forefront of new discovery. That is why we are protecting the science budget in real terms throughout this Parliament. This £23m fund provides invaluable support to help develop new ideas into the drugs and methods that will help save and improve lives.”